Shukra Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 201.6 million compared to INR 65.66 million a year ago. Revenue was INR 207.94 million compared to INR 65.74 million a year ago.

Net income was INR 4.2 million compared to INR 3.28 million a year ago. Basic earnings per share from continuing operations was INR 0.1475 compared to INR 0.5225 a year ago. Diluted earnings per share from continuing operations was INR 0.1475 compared to INR 0.5225 a year ago.